• Explore /
  • Poster
  • / Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S).

Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S).

Abstract Poster

Authors

null

Imane H. El Dika

Memorial Sloan Kettering Cancer Center, New York, NY

Imane H. El Dika , Marinela Capanu , Joanne F. Chou , James J. Harding , Anna D. Hrabovsky , Richard K. G. Do , Jinru Shia , Joseph Germino , Eileen Mary O'Reilly , Ghassan K. Abou-Alfa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT01840592

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4080)

DOI

10.1200/JCO.2018.36.15_suppl.4080

Abstract #

4080

Poster Bd #

269

Abstract Disclosures

Similar Posters

First Author: Ahmed Omar Kaseb

First Author: Tim Meyer

First Author: Mairead Geraldine McNamara

First Author: Silvia Stacchiotti